Àº»ê¹Ìµð¾î

ÀÇÇÐÀÇÇÐ

Àü¹®°¡Æò°¡ :
ÆäÀ̽ººÏ °øÀ¯Çϱâ Æ®À§ÅÍ·Î °øÀ¯Çϱâ Ä«Ä«¿À½ºÅ丮 °øÀ¯Çϱâ

Andrews' Diseases of the Skin, 13/e

  • Á¤ °¡263,900¿ø

    ÆǸŰ¡237,500¿ø(89%¡é, 26,400¿ø ÇÒÀÎ)

  • ÃâÆÇ»çElsevier

    ÀúÀÚWilliam D. James

    ISBN9780323547536

    ÃâÆdz⵵2019-04-12

    ÆäÀÌÁö1020page

  • ¼ö ·® Áõ°¡ °¨¼Ò
ÃÑ ÇÕ°è±Ý¾×237,500¿ø

Now in a fully revised thirteenth edition,
Andrews' Diseases of the Skin
remains your
single-volume, must-have resource for core information in dermatology. From residency through clinical practice, this award-winning title ensures that you stay up to date with new tools and strategies for diagnosis and treatment, new entities and newly recognized diseases, and current uses for tried-and-true and newer medications. It's
the reference you'll turn to again and again
when faced with a clinical conundrum or therapeutically challenging skin disease.


Key Features
  • Utilizes a
    concise, clinically focused, user-friendly format
    that clearly covers the full range of common and rare skin diseases.
  • Provides access to
    approximately 20 videos online,
    depicting chemical peels, Q-switched laser tattoo removal, ED&C (electrodesiccation and curettage), nerve block, and more.
  • Provides outstanding visual support with
    1,340 illustrations - more than 500 new
    to this edition.
  • Presents
    comprehensively updated information throughout, including new and unusual clinical presentations of syphilis, new diagnostic classifications and therapies for vascular anomalies, and an updated pediatric and genodermatosis review.
  • Covers
    new and evolving treatments
    for inflammatory, neoplastic, and blistering skin diseases among others.¡¡ New biologics and phosphodiesterase inhibitors for psoriasis and atopic dermatitis, JAK inhibitors for alopecia areata and vitiligo, immune checkpoint inhibitors for melanoma and rituximab for pemphigus are all covered.
  • Features a
    revised and revamped cutaneous adverse drug reaction section, including novel eruptions from new and emerging chemotherapeutic agents and small molecule/targeted inhibitors.
  • Discusses
    new and emerging viruses
    including Zika and human polyomaviruses.
  • Enhanced eBook version included with purchase.
    Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.


¹è¼Û¾È³» 

- »óÇ°¼ö·É ±â°£Àº ÀԱݿϷáÈÄ 2~3ÀÏ À̳»¿¡ ¹è¼ÛÀÌ ¿Ï·áµÇ¸ç (¿µ¾÷ÀÏ ±âÁØ, °øÈÞÀÏ ¹× õÀçÁöº¯Àº Á¦¿Ü) ÁÖ¹®ÇϽŠ»óÇ°¿¡ µû¶ó ¹è¼Û±â°£ÀÌ º¯°æµÉ ¼ö ÀÖ½À´Ï´Ù.
- ÇØ¿ÜÁÖ¹®À¸·Î ÁøÇàµÉ °æ¿ì 4~5ÁÖ ¼Ò¿ä µÉ ¼ö ÀÖ½À´Ï´Ù.
- »óÇ°±¸¸Å ±Ý¾×ÀÌ 25,000¿ø ¹Ì¸¸ÀÎ °æ¿ì ¹è¼Ûºñ 3,000¿øÀ» ºÎ´ãÇÏ¼Å¾ß ÇÕ´Ï´Ù.
- µµ¼­»ê°£Áö¹æÀº ±âº» ¹è¼Ûºñ ÀÌ¿Ü¿¡ Ãß°¡ ¹è¼Ûºñ°¡ Ãß°¡µÉ ¼ö ÀÖ½À´Ï´Ù.
- ÁÖ¹®ÇϽŠ»óÇ°Àº ·ÎÁ¨Åùè·Î ¹è¼ÛµÇ¸ç ÁÖ¹®/¹è¼ÛÁ¶È¸¿¡¼­ ¹è¼ÛÇöȲÀ» Á¶È¸ÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.

Ãë¼Ò/±³È¯/¹ÝÇ°¾È³»
- ÀÔ±Ý/°áÁ¦¿Ï·á ÀÌÀü¿¡´Â ¹Ù·Î ÁÖ¹®/¹è¼ÛÁ¶È¸¿¡¼­ Ãë¼ÒÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
- ÀÔ±Ý/°áÁ¦ ¿Ï·á½Ã ÀÔ±ÝÈ®ÀÎ °Ô½ÃÆÇ ¶Ç´Â °í°´¼¾ÅÍ(02-739-9531)·Î ¿¬¶ôÁֽøé Ãë¼Ò/±³È¯/¹ÝÇ°ÀÌ °¡´ÉÇÕ´Ï´Ù.
- »óÇ°ÀÇ ÇÏÀÚ°¡ Àִ°æ¿ì ¼ö·ÉÈÄ 7ÀÏ À̳» ±³È¯ ¹× ¹ÝÇ°ÇÏ½Ç ¼ö ÀÖÀ¸¸ç ¹è¼Ûºñ´Â ¼îÇθô¿¡¼­ ºÎ´ãÇÕ´Ï´Ù.
- Æ÷Àå ¶Ç´Â ³»¿ë¹°ÀÌ ÈÑ¼ÕµÇ¾î »óÇ°°¡Ä¡°¡ »ó½ÇµÈ °æ¿ì ¹ÝÇ°±³È¯ÀÌ ºÒ°¡´ÉÇÕ´Ï´Ù.
- °í°´´ÔÀÇ ¸¶À½ÀÌ ¹Ù²î¾î ±³È¯/¹ÝÇ° ½Ã ¿Õº¹ ¹è¼Û·á´Â °í°´´ÔºÎ´ãÀÔ´Ï´Ù.